Summary & Overview
CPT 83721: Direct Measurement of LDL Cholesterol
CPT code 83721 represents a direct measurement of low density lipoprotein (LDL) cholesterol performed by a laboratory analyst on a patient specimen. Direct LDL measurement is clinically important for assessing cardiovascular risk and guiding lipid-lowering therapies, especially in patients with hypertriglyceridemia or when calculated LDL may be unreliable. Nationally, accurate LDL measurement supports preventive cardiology and chronic disease management programs.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for when direct LDL testing is used, common sites of service, and the role of this test within laboratory and cardiometabolic care pathways. The publication provides benchmarks and policy-relevant information about coverage patterns and coding practice where available.
The analysis also summarizes typical service settings, conveys common billing modifiers when relevant, and highlights gaps where input data is not available. This resource is intended for billing professionals, laboratory managers, and policy analysts who need a concise reference on the clinical meaning, payer landscape, and administrative considerations associated with CPT code 83721.
Billing Code Overview
CPT code 83721 describes a laboratory test in which a lab analyst directly measures low density lipoprotein (LDL) cholesterol in a patient specimen. This is a clinical chemistry diagnostic procedure that yields a direct quantitative LDL-C value rather than an estimated value derived from other lipid panel components.
Service Type: Laboratory test — direct LDL cholesterol measurement
Typical Site of Service: Clinical laboratory or hospital laboratory
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult primary care or cardiology patient undergoing lipid evaluation for cardiovascular risk assessment or management of dyslipidemia. A 58-year-old patient with hypertension and type 2 diabetes presents for routine follow-up and medication management. The clinician orders a direct low-density lipoprotein cholesterol test to accurately quantify LDL-C when triglycerides are elevated, when non-HDL calculations are unreliable, or when precise measurement is needed for high-risk therapeutic decisions. A phlebotomy technician collects a fasting or non-fasting blood specimen in the outpatient clinic or hospital laboratory. The specimen is processed and analyzed by a laboratory technologist using a validated direct LDL assay; the laboratory analyst documents results and reports them into the electronic medical record. Typical sites of service include outpatient clinic laboratories, hospital clinical laboratories, and independent reference laboratories.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician/interpretive portion if separate technical component is billed by the lab. |
TC | Technical component |